Clinical Trials Directory

Trials / Completed

CompletedNCT02057367

Scalp Nerve Block and Opioid Consumption in Brain Surgery

The Effect of Pre-incisional Anterior Scalp Block on Intraoperative Opioid Consumption in Adult Patients Undergoing Elective Craniotomy to Remove Tumor: A Prospective Randomized Controlled

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Chiang Mai University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Anterior scalp block with 0.5% plain Marcaine 20 ml. may reduce the intraoperative opioid consumption in neurosurgical patients who undergoing the supratentorial craniotomy compared to those who receive 0.9% normal saline solution (placebo).

Detailed description

Anterior scalp block with 0.5% plain Marcaine 20 ml. may reduce the intraoperative opioid consumption in neurosurgical patients who undergoing the supratentorial craniotomy compared to those who receive 0.9% normal saline solution (placebo). A Prospective Randomized Double Blind Control

Conditions

Interventions

TypeNameDescription
DRUGScalp block with 0.5% plain MarcaineAnterior scalp block will be done by using 0.5% plain Marcaine 20 ml.
DRUGScalp block with 0.9% normal salineAnterior scalp block will be done by using 0.9% normal saline 20 ml.

Timeline

Start date
2013-03-01
Primary completion
2016-02-01
Completion
2016-04-01
First posted
2014-02-07
Last updated
2016-07-27

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT02057367. Inclusion in this directory is not an endorsement.